Adicet Bio, Inc. (0HX7.L)

USD 0.92

(-3.81%)

Eps Summary of Adicet Bio, Inc.

  • Adicet Bio, Inc.'s latest annual eps in 2023 was -3.31 USD , down -94.71% from previous year.
  • Adicet Bio, Inc.'s latest quarterly eps in 2024 Q2 was -0.33 USD , up 5.71% from previous quarter.
  • Adicet Bio, Inc. reported an annual eps of -1.70 USD in 2022, up 15.0% from previous year.
  • Adicet Bio, Inc. reported an annual eps of -2.00 USD in 2021, up 60.08% from previous year.
  • Adicet Bio, Inc. reported a quarterly eps of -0.35 USD for 2024 Q1, up 49.28% from previous quarter.
  • Adicet Bio, Inc. reported a quarterly eps of -0.72 USD for 2023 Q1, down 0.0% from previous quarter.

Annual Eps Chart of Adicet Bio, Inc. (2023 - 2016)

Historical Annual Eps of Adicet Bio, Inc. (2023 - 2016)

Year Eps Eps Growth
2023 -3.31 USD -94.71%
2022 -1.70 USD 15.0%
2021 -2.00 USD 60.08%
2020 -5.01 USD 61.9%
2019 -13.15 USD -32.03%
2018 -9.96 USD 83.11%
2017 -58.97 USD -29484900.0%
2016 -0.00 USD 0.0%

Peer Eps Comparison of Adicet Bio, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD -63.861%
Dynavax Technologies Corporation -0.05 USD -6573.387%
Supernus Pharmaceuticals, Inc. 0.02 USD 13834.44%
Perrigo Company plc -0.09 USD -3425.027%
Illumina, Inc. -7.35 USD 54.966%
Thermo Fisher Scientific Inc. 15.53 USD 121.314%
Iovance Biotherapeutics, Inc. -1.89 USD -75.132%
Walgreens Boots Alliance, Inc. -10.01 USD 66.933%
IQVIA Holdings Inc. 7.39 USD 144.79%
Heron Therapeutics, Inc. -0.80 USD -313.75%
Regeneron Pharmaceuticals, Inc. 37.05 USD 108.934%
Unity Biotechnology, Inc. -2.70 USD -22.593%
Waters Corporation 10.87 USD 130.451%
Biogen Inc. 8.02 USD 141.272%
Sangamo Therapeutics, Inc. -1.48 USD -123.649%
Evolus, Inc. -1.08 USD -206.481%
Cara Therapeutics, Inc. -2.19 USD -51.142%
bluebird bio, Inc. -1.93 USD -71.503%
Esperion Therapeutics, Inc. -2.03 USD -63.054%
FibroGen, Inc. -2.92 USD -13.356%
Agilent Technologies, Inc. 4.22 USD 178.436%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 67.895%
Homology Medicines, Inc. -7.41 USD 55.331%
Geron Corporation -0.32 USD -934.375%
Alnylam Pharmaceuticals, Inc. -3.52 USD 5.966%
Amicus Therapeutics, Inc. -0.51 USD -549.02%
Myriad Genetics, Inc. -1.39 USD -138.129%
Viking Therapeutics, Inc. -0.91 USD -263.736%
Intellia Therapeutics, Inc. -5.42 USD 38.93%
Zoetis Inc. 5.08 USD 165.157%
Abeona Therapeutics Inc. -2.53 USD -30.83%
Mettler-Toledo International Inc. 36.10 USD 109.169%
BioMarin Pharmaceutical Inc. 0.89 USD 471.91%
Vertex Pharmaceuticals Incorporated 14.05 USD 123.559%
Kala Pharmaceuticals, Inc. -17.35 USD 80.922%
Ionis Pharmaceuticals, Inc. -2.56 USD -29.297%
Atara Biotherapeutics, Inc. -65.18 USD 94.922%
Verastem, Inc. -3.96 USD 16.414%
Nektar Therapeutics -1.45 USD -128.276%
Axsome Therapeutics, Inc. -5.27 USD 37.192%
Aclaris Therapeutics, Inc. -1.27 USD -160.63%
Sarepta Therapeutics, Inc. -5.80 USD 42.931%
OPKO Health, Inc. -0.25 USD -1224.0%
Exelixis, Inc. 0.65 USD 609.231%
Neurocrine Biosciences, Inc. 2.56 USD 229.297%
Corcept Therapeutics Incorporated 1.02 USD 424.51%
Anavex Life Sciences Corp. -0.60 USD -451.667%
uniQure N.V. -6.47 USD 48.841%
Imunon, Inc. -2.16 USD -53.241%
Blueprint Medicines Corporation -8.37 USD 60.454%
Insmed Incorporated -5.34 USD 38.015%
Halozyme Therapeutics, Inc. 2.13 USD 255.399%
Agios Pharmaceuticals, Inc. -6.33 USD 47.709%
TG Therapeutics, Inc. 0.09 USD 3806.607%
Incyte Corporation 2.67 USD 223.97%
Emergent BioSolutions Inc. -14.85 USD 77.71%